A member of a panel advising the government on the safety of a medical device that can spread cancer in women stepped down after the Food and Drug Administration reviewed consulting fees he accepted from a device manufacturer, the agency said Thursday.
Doctor quits uterine-device safety panel over conflict
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.